2002
DOI: 10.1053/hupa.2002.31292
|View full text |Cite
|
Sign up to set email alerts
|

Cyclooxygenase-2 expression in endometrial cancer: Correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
71
0
4

Year Published

2004
2004
2018
2018

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 112 publications
(77 citation statements)
references
References 26 publications
2
71
0
4
Order By: Relevance
“…[12][13][14] To account for the fact that tumor-produced COX-2 might be an immunosuppressive effector, there are several possible explanations.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[12][13][14] To account for the fact that tumor-produced COX-2 might be an immunosuppressive effector, there are several possible explanations.…”
Section: Discussionmentioning
confidence: 99%
“…Among several possibilities, cyclooxygenase (COX) has received much attention recently for immunosuppression of antitumor immunity, as well as inflammation, carcinogenesis, 7,8 apoptosis, 9,10 metastasis, 11 angiogenesis [12][13][14] and poor prognosis. [15][16][17] Recent studies of in vitro or animal models have revealed that COX-2 may be a critical factor in enabling carcinoma cells to escape host immune defenses by modulation of cytokine production, 18 dysfunction of dendritic cells 19 and suppression of lymphocyte proliferation.…”
mentioning
confidence: 99%
“…Recently, it has been reported that COX-2 works on angiogenesis associated with tumor growth and advancement in the following tumors: advanced ovarian serous carcinomas [21], uterine endometrial cancers [22], breast cancers [23], gastric cancers [24], renal cell carcinomas [25], head and neck squamous cell carcinoma [26] and colon cancers [27]. Colon cancer cell line HCA-7 cells overexpress COX-2 and co-express VEGF, bFGF, transforming growth factor (TGF)-beta and platelet-derived growth factor (PDGF) [27].…”
Section: Introductionmentioning
confidence: 99%
“…The scoring methods were modified by Fujiwaki et al (26). Namely, the percentage of COX-1 and -2 immunostaining in the glandular and stromal cells were graded as follows: 0, no staining; 1, 1-25%; 2, 26-50%; 3, 51-75%; and 4, 76-100%.…”
Section: Immunohistochemical Expression Of Cox-1/2 Il-1· and Tnf-· Pmentioning
confidence: 99%
“…ranged from 0 to 12 (26). The immunohistochemical findings were analyzed by two independent investigators counting >200 cells and discordant results were reviewed jointly.…”
Section: Immunohistochemical Expression Of Cox-1/2 Il-1· and Tnf-· Pmentioning
confidence: 99%